The 20 Best Malignant Peripheral Nerve Sheath Tumor Doctors Near Me

Dr. Christine Pratilas is a pediatric medical oncologist at the Sidney Kimmel Comprehensive Cancer Center and Associate Professor of Oncology, Pediatrics & Cellular and Molecular Medicine at the Johns Hopkins University School of Medicine. She joined the Hopkins pediatric sarcoma team in 2014. Dr. Pratilas received her undergraduate degree in Biology from Drew University in New Jersey and her medical degree from UMDNJ - Robert Wood Johnson Medical School (now Rutgers University), where she also completed her internship and residency from 1999 to 2002. From 2002 to 2005 she was a fellow in hematology and oncology in the Memorial Sloan Kettering Cancer Center (MSKCC) Department of Pediatrics, and in the Department of Pediatric Hematology and Oncology at New York Weill Cornell Medical Center. She was a postdoctoral research fellow in Dr. Neal Rosen’s Molecular Oncogenesis Laboratory at MSKCC. From 2006 to 2014 she was attending in Pediatric Oncology at MSKCC, specializing in developmental therapeutics & sarcoma. She has been the director of the pediatric sarcoma program at Hopkins since 2018. Dr. Pratilas focuses her research on cancer-associated pathways and signal transduction, which involves figuring out how a cell’s internal molecular pathways work, and how those pathways can be molecularly controlled. This knowledge is the basis for developing promising new molecularly targeted cancer therapies, which is the focus of Dr. Pratilas’s research. Among her important scientific contributions is advancing our understanding of how certain proteins that can be mutated in cancer, known as RAF kinases (specifically BRAF), affect a cancer cell’s behavior. The research in Dr. Pratilas' laboratory is focused on RAS signal transduction pathways, concentrating on pediatric sarcomas such as rhabdomyosarcoma and malignant peripheral nerve sheath tumors, in order to develop novel therapeutics for children with these tumors. Dr. Pratilas is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. Her top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Adult Soft Tissue Sarcoma, and Osteotomy.

Angela Hirbe is an Oncologist in Saint Louis, Missouri. Dr. Hirbe is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. Her top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Neurofibromatosis Type 1 (NF1), and Adult Soft Tissue Sarcoma.

Brigitte Widemann is a Hematologist and an Oncologist in Bethesda, Maryland. Dr. Widemann is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. Her top areas of expertise are Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Malignant Peripheral Nerve Sheath Tumor, Adult Soft Tissue Sarcoma, and Thyroidectomy.

Steven Carroll is a primary care provider, practicing in Internal Medicine in Augusta, Georgia. Dr. Carroll is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. His top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Neurofibromatosis Type 1 (NF1), and Neurofibromatosis.

Ping Chi is an Oncologist in New York, New York. Dr. Chi is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. Her top areas of expertise are Gastrointestinal Stromal Tumor, Malignant Peripheral Nerve Sheath Tumor, Undifferentiated Pleomorphic Sarcoma, Adult Soft Tissue Sarcoma, and Endoscopy. Dr. Chi is currently accepting new patients.

Enrico Martin practices in Utrecht, Netherlands. Mr. Martin is rated as an Elite expert by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. His top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Neurofibromatosis, and Neurofibromatosis Type 1 (NF1).

Cleofe Romagosa practices in Barcelona, Spain. Romagosa is rated as an Elite expert by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. Their top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Adult Soft Tissue Sarcoma, and Neurofibromatosis.

Adrienne Flanagan practices in Stanmore, United Kingdom. Ms. Flanagan is rated as an Elite expert by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. Her top areas of expertise are Chordoma, Malignant Peripheral Nerve Sheath Tumor, Adult Soft Tissue Sarcoma, and Bone Tumor.

Johannes Salamon practices in Bad Oldesloe, Germany. Mr. Salamon is rated as an Elite expert by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. His top areas of expertise are Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, and Angioplasty.

Robert Spinner is a Neurosurgery provider in Rochester, Minnesota. Dr. Spinner is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. His top areas of expertise are Accessory Deep Peroneal Nerve, Mononeuritis Multiplex, Erb's Palsy, Nerve Decompression, and Tissue Biopsy.

Victor Mautner practices in Hamburg, Germany. Mautner is rated as an Elite expert by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. Their top areas of expertise are Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Malignant Peripheral Nerve Sheath Tumor, and Fibrosarcoma.

Rashmi Chugh is an Oncologist in Ann Arbor, Michigan. Dr. Chugh is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. Her top areas of expertise are Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma.

Joseph Pressey is a Hematologist and an Oncologist in Cincinnati, Ohio. Dr. Pressey is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. His top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Ewing Sarcoma, Adult Soft Tissue Sarcoma, and Osteosarcoma.

William Tap is an Oncologist in New York, New York. Dr. Tap is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. His top areas of expertise are Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Angiosarcoma, Tissue Biopsy, and Liver Embolization. Dr. Tap is currently accepting new patients.

. Dr. Shipstone is rated as an Experienced provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. His top areas of expertise are Adult Immune Thrombocytopenia, Colorectal Cancer, Hemangioma Thrombocytopenia Syndrome, and Thrombocytopenia.

Bradley Beeler, MD, provides comprehensive care for patients with all stages of oncological malignancies and the full spectrum of hematological conditions. His expertise includes the treatment and management of benign and malignant hematologic disorders, bone marrow failure syndromes, transfusion support and advanced cellular therapies. He has specialized training in hematopoietic stem cell transplantation and cellular therapy, offering advanced options for eligible patients. A former Lieutenant Colonel in the United States Air Force, Dr. Beeler served more than 10 years on active duty, caring for service members, retirees and their families. “Helping patients reach milestones they feared they wouldn’t see, like attending a graduation or holding a grandchild, is what makes this work so meaningful,” he says. As an ETSU Health clinician, Dr. Beeler also serves as a faculty member at ETSU’s Quillen College of Medicine. Originally from Knoxville, he is grateful to return to the Appalachian Highlands and enjoys spending time outdoors with his wife and children. Dr. Beeler is rated as an Experienced provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. His top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Hemolytic Transfusion Reaction, and Parathyroid Cancer.

Dr. Meyer will serve as the lead medical oncologist for adult sarcoma patients, and will focus on building the Adult Sarcoma and Connective Tissue Oncology Program. In collaboration with pediatric oncologist David Loeb, M.D., Ph.D., and orthopaedic surgeon Kristy Weber, M.D., Meyer will bring novel therapies to the clinic for sarcoma patients. Meyer received his bachelors and masters degrees in cell and molecular biology from Stanford University. From there, he joined the Medical Scientist Training Program at Baylor College of Medicine and earned his medical degree followed by a doctorate in immunology. Meyer completed his residency at the University of Maryland and served as chief resident in medicine from 2004-2005. Afterward, he joined our fellowship program in medical oncology and has been working in the laboratory of Jonathan Powell, M.D., Ph.D., on projects relating to the characterization of molecular regulatory pathways involved in T-cell activation and energy. As a third-year fellow, Meyer served as the chief fellow for our Training Programs in Hematology and Medical Oncology and he received a Young Investigator Award from the American Society of Clinical Oncology in 2010. Dr. Meyer is rated as a Distinguished provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. His top areas of expertise are Adult Soft Tissue Sarcoma, Rhabdomyosarcoma, Fibrosarcoma, Osteosarcoma, and Salpingo-Oophorectomy.

Gulam Manji, M.D., Ph.D. is an Associate Professor of Medicine at Columbia University Medical Center. Dr. Manji received his M.D. degree from Ross University School of Medicine in 2009 and completed his residency in internal medicine at Albany Medical College. He then completed his fellowship in Hematology/Oncology at NewYork-Presbyterian/Columbia, where his clinical focus was on the treatment of gastrointestinal malignancies, melanoma, and sarcoma under the mentorship of Dr. Gary Schwartz, Chief of Hematology and Oncology.Dr. Manji conducts translational research with the overall goal to developing new treatments for cancer. His focus is in gastrointestinal malignancies, particularly pancreas adenocarcinoma, on which he is conducting preclinical combination immunotherapy studies on genetically engineered mice with pancreas cancer in the Olive laboratory at the Herbert Irving Comprehensive Cancer Center. The combination immunotherapy preclinical proposal received the Young Investigator Award from the American Society of Clinical Oncology-2015. The goal of these preclinical studies is to bring promising new therapies to the clinic in an early phase clinical trials Dr. Manji's research career in identifying new genes and their implication in disease has led to numerous key publications and an issued patent.Dr. Manji cares for patients with gastrointestinal malignancies, with a particular focus on pancreatic and liver cancers, and sarcomas. He is the principal investigator of an investigator-initiated multicenter clinical trial that he wrote with Dr. Gary Schwartz in sarcoma and malignant peripheral nerve sheath tumors and is responsible for clinical trials conducted in liver, bile duct, gallbladder, and pancreas cancers at Columbia University Medical Center. Dr. Manji is rated as a Distinguished provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Malignant Peripheral Nerve Sheath Tumor, and Familial Pancreatic Cancer.

Dr. Ready is a member of the Department of Orthopaedic Surgery and is Chief of the Orthopaedic Oncology Service. In this role, Dr. Ready treats cancer patients with bone and soft tissue sarcoma, as well as patients with metastatic bone disease. He received subspecialty training in this field at Massachusetts General Hospital and Children’s Hospital Boston. He is an intricate member of a multidisciplinary treatment team that includes Medical Oncologists, Radiation Oncologists, Pathologists, Radiologists and other Surgical Subspecialists.  Patients may be seen at the Brigham and Women’s Hospital or at the Dana-Farber Cancer Institute. In addition to Orthopaedic Oncology, Dr. Ready has specialty training in reconstructive arthroplasty surgery of the hip and knee. He performs direct anterior approach total hip replacement, total knee replacement (including Mako robotic knee replacement) and complex cases of revision total hip and total knee arthroplasty.  He is also part of a team that performs Day Surgery total joint replacement at Brigham and Women's Hospital and Brigham and Women's Faulkner Hospital. Dr. Ready is rated as a Distinguished provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. His top areas of expertise are Bone Tumor, Ewing Sarcoma, Osteoarthritis, Hip Replacement, and Knee Replacement.

. Dr. Katz is rated as an Experienced provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. Her top areas of expertise are Lung Cancer, Mesothelioma, Pleural Effusion, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.